Edition:
United Kingdom

Caplin Point Laboratories Ltd (CAPL.NS)

CAPL.NS on National Stock Exchange of India

638.95INR
14 Dec 2017
Change (% chg)

Rs3.90 (+0.61%)
Prev Close
Rs635.05
Open
Rs649.70
Day's High
Rs649.70
Day's Low
Rs632.55
Volume
19,591
Avg. Vol
74,980
52-wk High
Rs784.80
52-wk Low
Rs328.00

Select another date:

Thu, Nov 9 2017

BRIEF-India's Caplin Point Laboratories Sept-qtr consol profit rises

* Sept quarter consol profit 355.7 million rupees versus profit of 224.1 million rupees year ago

BRIEF-Caplin Point Laboratories gets U.S. FDA approval for ketorolac tromethamine injection

* Says gets FDA approval for ketorolac tromethamine injection 30 mg/ml in U.S.

BRIEF-Caplin Point Labs approves re-appointment of Sridhar Ganesan as MD‍​

* Says approved re-appointment of Sridhar Ganesan as MD‍​ Source text for Eikon: Further company coverage:

BRIEF-India's Caplin Point Laboratories June-qtr consol profit rises

* June quarter consol profit 363.2 million rupees versus profit 159.8 million rupees year ago

Select another date: